greeksoup/ stock research

Ethos Technologies Inc.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 25 February 2026: press release. The quarter’s numbers.

Key takeaways

  • Revenue grew 65% in Q4: Fourth-quarter revenue was $110.1 million, up 65% from a year earlier. Full-year revenue was $387.6 million, up 52%. Source
  • Diluted EPS rose to $0.42: Q4 net income was $24.6 million, a 22% margin, and diluted EPS was $0.42 against $0.16. Full-year net income was $71.2 million and diluted EPS $1.22 against $0.85. Source
  • Direct channel grew 93% in Q4: Direct channel revenue was $74.2 million in the fourth quarter. For the full year, direct channel revenue was $242.5 million, up 40%. Source
  • Lifetime policies passed 500,000: The company activated 54,714 new policies in Q4, up 42%, bringing lifetime policies to over 500,000. Source
  • Two new products launched in Q4: The company launched Accumulation Indexed Universal Life with North American Sammons and Cancer Insurance with Aflac during the quarter. Source
  • Adjusted EBITDA margin of 23%: Adjusted EBITDA was $25.8 million in Q4 at a 23% margin, and $89.0 million for the year, also at a 23% margin. Source
  • Cash and investments reached $157.4 million: Cash, cash equivalents and investments were $157.4 million at December 31, 2025. Cash and cash equivalents were $91.1 million, up from $35.1 million. Source
  • Full-year revenue range raised to 2026 view: Full-year 2026 revenue is expected between $510.0 million and $514.0 million, a 32% increase at the midpoint. Source

“We delivered a strong close to 2025 with 65% year-over-year revenue growth in Q4,”

Peter Colis, CEO and Co-Founder of Ethos

Guidance

AreaPeriodFigureAgainst last quarter
Total revenue Sourcefirst quarter of 2026$144.0 million to $146.0 million
Adjusted EBITDA Sourcefirst quarter of 2026$30.0 million to $32.0 million
Total revenue Sourcefiscal year 2026$510.0 million to $514.0 million
Adjusted EBITDA Sourcefiscal year 2026$99.0 million to $103.0 million

What changed from last quarter

  • New: Two new products launched in the fourth quarter: Accumulation Indexed Universal Life with North American Sammons, and Cancer Insurance with Aflac. Source

Fourth quarter and full-year results

  • Revenue grew 65% in Q4: Fourth-quarter revenue was $110.1 million, up 65% from a year earlier. Full-year revenue was $387.6 million, up 52%. Source
  • Third straight year above 50%: The company said 2025 was its third consecutive year of revenue growth greater than 50%. Source
  • Diluted EPS rose to $0.42: Q4 net income was $24.6 million, a 22% margin, and diluted EPS was $0.42 against $0.16. Full-year net income was $71.2 million and diluted EPS $1.22 against $0.85. Source
  • Q4 operating cash flow was $4.9 million: The company reported net cash generated from operations of $4.9 million in the fourth quarter. Source

Channel revenue mix

  • Direct channel grew 93% in Q4: Direct channel revenue was $74.2 million in the fourth quarter. For the full year, direct channel revenue was $242.5 million, up 40%. Source
  • Third-party channel up 79% for year: Full-year third-party channel revenue was $145.1 million, up 79%. Source
  • Third-party channel up 27% in Q4: Fourth-quarter third-party channel revenue was $35.9 million, up 27% from a year earlier. Source

“Our financial results demonstrate not only exceptional topline growth but also continued evidence of Ethos’ significant earnings potential.”

Peter Colis, CEO and Co-Founder of Ethos

Policies, products and network

  • Lifetime policies passed 500,000: The company activated 54,714 new policies in Q4, up 42%, bringing lifetime policies to over 500,000. Source
  • Two new products launched in Q4: The company launched Accumulation Indexed Universal Life with North American Sammons and Cancer Insurance with Aflac during the quarter. Source
  • Agent and carrier network: Over 15,000 agents were selling on the platform at the end of 2025. The company reported six carriers in its network at quarter-end. Source
  • Mission centred on family protection: Management described the company's mission as protecting families by democratizing access to life insurance. Source

Costs and expenses rose

  • Sales and marketing costs rose: Fourth-quarter sales and marketing expense was $64.1 million, against $40.1 million a year earlier. Full-year expense was $229.3 million, against $148.7 million. Source
  • G&A and technology spend increased: General and administrative expense was $9.2 million in Q4, against $4.7 million. Technology expense, excluding amortization, was $8.9 million, against $6.4 million. Source
  • Stock-based compensation lower in Q4: Stock-based compensation was $32 thousand in Q4, against $897 thousand a year earlier. Full-year stock-based compensation was $10.6 million, against $3.2 million. Source

“We are on a mission to protect families by democratizing access to life insurance, and reaching the milestone of 500,000 policies activated is a testament to that deep commitment.”

Peter Colis, CEO and Co-Founder of Ethos

Margins and per-share earnings

  • Gross margin held at 98%: Gross profit was $108.0 million in Q4 and $380.9 million for the year, each at a 98% gross profit margin. Source
  • Adjusted EBITDA margin of 23%: Adjusted EBITDA was $25.8 million in Q4 at a 23% margin, and $89.0 million for the year, also at a 23% margin. Source
  • Contribution margin 43% in Q4: Contribution profit was $47.2 million in Q4, a 43% margin, and $162.0 million for the year, a 42% margin. Source
  • Non-GAAP diluted EPS of $1.40: Non-GAAP diluted EPS was $1.40 for the year, against $0.90. The company's non-GAAP measure excludes stock-based compensation. Source

Cash, balance sheet and capital

  • Cash and investments reached $157.4 million: Cash, cash equivalents and investments were $157.4 million at December 31, 2025. Cash and cash equivalents were $91.1 million, up from $35.1 million. Source
  • Full-year operating cash flow positive: Full-year operating cash flow was $36.2 million, against a use of $10.9 million in 2024. Investing activities provided $31.9 million and financing activities used $12.0 million. Source
  • Long-term commissions receivable grew: Long-term commissions receivable rose to $224.2 million from $173.1 million at year-end. Source
  • Offering costs and receivable repayments: Financing activities included $6.2 million of payments of deferred offering costs and $12.0 million of repayments of liabilities related to sale of commissions receivable. Source
  • Stockholders' deficit narrowed: Total stockholders' deficit was $24.1 million at year-end, against $107.2 million a year earlier. Accumulated deficit was $102.5 million, against $173.7 million. Source

2026 revenue and EBITDA ranges

  • First-quarter ranges given: For the first quarter of 2026, revenue is expected between $144.0 million and $146.0 million, and Adjusted EBITDA between $30.0 million and $32.0 million. Source
  • Full-year revenue range raised to 2026 view: Full-year 2026 revenue is expected between $510.0 million and $514.0 million, a 32% increase at the midpoint. Source
  • Full-year Adjusted EBITDA range: Full-year 2026 Adjusted EBITDA is expected between $99.0 million and $103.0 million. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.